AGTR2 and pulmonary embolism: This, on the other hand, could explain why angiotensin-2 receptor blockers reduce the risk of pulmonary embolism, especially in a possible subpopulation that requires a combination of angiotensin-2 receptor blockers and diuretics and may have higher risk of atherosclerotic disease63.